SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-24-005321
Filing Date
2024-06-26
Accepted
2024-06-26 17:37:29
Documents
2
Period of Report
2024-06-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1732
2 POA poa_eostrowskijun24.txt EX-24 3434
  Complete submission text file 0001562180-24-005321.txt   6604
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AVROBIO, INC. ONE KENDALL SQUARE, BLDG. 300, #201 CAMBRIDGE MA 02139
Business Address
Ostrowski Erik (Reporting) CIK: 0001762507 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36352 | Film No.: 241074703